LOUISE RODINO-KLAPAC, PH.D.

Corporate Board Profile

Tech Score: 0/100

← Back to All Directors

Sarepta Therapeutics, Inc.

Filing Date Source Excerpt
2022-04-25 Louise Rodino-Klapac, Ph.D., has served as our Executive Vice President, Chief Scientific Officer since December 2020. Dr. Rodino-Klapac was additionally appointed as our Head of R&D in November 2021.

Data sourced from SEC filings. Last updated: 2025-12-07